Biocon Biologics Ltd., a subsidiary of Bangalore, India-headquartered Biocon Ltd., announced a strategic out-licensing agreement with Japan-based pharmaceuticals company Yoshindo Inc., for commercializing two of its pipeline biosimilar assets. Under the terms of this deal, Biocon Biologics will receive an upfront license fee as well as additional payments on the...